Evaluation of Neuroprotective Activity of Chrysin Nanoparticles Using Scopalamine Induced Neuroinflammation in the Rat Model of Alzheimer’s Disease
Abstract
Background: scopolamine induced neuroinflammation limits its long-term clinical use. Several agents/strategies were attempted to prevent scopolamine neuroinflammatory but were not found suitable for clinical use.
Objective: To investigate the neuroprotective activity of chrysin nanoparticle on scopolamine induced neuroinflammation.
Material and Method: Male Albino wistarrats (180- 230 grms) were evenly divided into 5 groups. Group I&II served as control (distilled water 10ml/kg) and diseases control (scopolamine) 100mg/kg per os treated for 4 weeks, group III served as standard group which received Donepezil (1.5mg/kg) on ,while group IV and V are simultaneously treated with (50mg/kg and 100 mg/kg) orally with chrysin nanoparticle up to 4 weeks. On 29 and 30 day behavioral parameters and brain were isolated for biochemical parameters at the same time rat brains were used for histological studies.
Results: Treatment of scopolamine caused neuroinflammation as the evidence by marked elevation in AchE, GSH, catalase, super oxide Dismutase, Elevated plus maze,Y-maze and Open field test. SLN chrysin decrease in AchE, catalase, super oxide dismutase, GSH time respectively. SLN chrysin increase activities of SOD, crossing, Rearing, Grooming. Histopathological changes also showed the protective nature SLN chrysin induced neuroinflammation
Downloads
References
2. Tayebati SK. “Animals models of cognitive dysfunction”. Mechanisms of Ageing and Development 127.2 (2006).
3. Berg, P.A., Daniel, P.T.,1988. In: Cody,V., Middeltion, E., Harbone, J.B., Beretz,A.(Eds.),plant Flavonoids in Biology and Medicine.II. Biochemical, cellular, and Medicinal properties. Liss Ince., New York,pp.17-27.
4. Gasco, M.R., Inventor.1993. Method for producing solid lipid Microspheres Having a Narrow size Distribution. United States Patent US 52520236A.
5. Trombino, S., Cassano, R., Ferrarelli, T., et al., 2013.Trans-ferulic acid based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Colloids Surf. B: Biointerfaces 109,273-279.
6. Kaur, I.p., Bhandari, R., Bhandari, S., 2008. Potential of solid lipid nanoparticles in brain targeting. J. Control. Release 127, 97-109.
7. A. Dinda, I. Biswal, P. Chowdhury, R. Mohapatta 2013. Formulation Development and Evaluation of Paclitaxel Loaded Solid Lipid Nanoparticle Using Glyceryl Monostearate Journal of Applied Pharmaceutical science Vol.3 (08). PP. 133-138.
8. Neel Kumar Dhami, Upendra Kumar Jain, Jitender Madam 2013. Non- aggregated protamine coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug derlivery and improved therapeutic index in glioblastoma cells: in vitro studies. Journal of microcapsulation. PP.1-14.
9. Munekazu Komada, Keizo Tokao, Tsuyoshi Miyaka.2008. Elevated Plus Maze for mice. Journal of Visualization Experiments. PP.1-4.
10. Ann- Katrin Kraeuter, Paul C. Guest, and Zoltan Sarnyai.1916. The Y-Maze for Assessment of spital working and reference memory in mice. Pre -clinical models: Techniques and protocols, methods in molecular biology. PP.105-11.
11. Zheng Cao, San Wang, Chunyu Xiu Jjian Zhang, Yanfei Li. 2017. Hyper Peforatum Extract Attenuates Behavioral , Biochemical and Neurochemical Abnormalities in Alluminium chloride – induced Alzheimer’s Disease rats. Science direct biomedicine and pharmacotherapy. PP. 931-937.
12. Ellman,G.L, Country, K.D., Andres Jr., V., 1961. Feather -stone RM., Anew and Rapid colorimetric determination of acetylcholinesterase activity. Biochem pharmacol.7,88-95.
13. Aebi, H., 1984. Catalase in vitro, Methods Enzymol. 105, 121-126.
14. Asokan Prema, Udaiyappan Janakiraman, Tamarian Manivasagan, Arokiasamy Justin. 2015. Themozhi Neuroprotective effect of lycopene against MPTP induced experimental Parkinson’s disease in mice. Neuroscience letters.
15. Mohamed E. Elhadidy, Hussein G. Sawie, Nagwa A. Meguid, Yasser A. Khadrawy.2018. protective effective of ashwagandha (Withania Somnifrera) against neurotoxicity induced by aluminium chloride in rats. Asian pacific Journal of Tropical Biochemicine:8(1):59-66.
16. Leon Jesus German-ponciano, Oscar Jeronimo Olmos- Vazquez, Abraham Puga- Olguin. 2022. Pharmacological ,Neurochemical and Behavioral mechanisms underlying the Aniolytic and Antidepressant -like effect of flavonoid chrysin. Molecules .PP 1-17.
17. 17.Taiyang Lio, Liang Ding, Li Zhang, xiaochen, Bo Xu, Haosheng, Zhenyuan Ma. 2022. Chrysin Attenuates the NLRP3 Inflammasome cascade to Reduce synovitis and pain in KOA Rat. Drug Design , Development and therapy. PP. 3015-3027.
18. Basit L. Jan , Ajaz Ahmad, Muneeb U, Rehman, and khalid M. Alkhafy, Altaf Khan. 2012. Protective effect of chrysin, a flavonoid on the genotoxic activity of carboplatin in mice. Drug and chemical toxicology. PP. 1-7.
19. Sumathi Thangarajain , Aishwarya Vedagiri . 2016. Mitigating effect of chrysin loaded solid lipid nanoparticle against Amyloid β25-35 induced oxidative stress in rat hippocampal region: an efficient formulation approach for Alzheimer’s disease. Nano peptide. PP1-11.
20. Busi Siddharadha ,Uday pandey,K. kaviyarasu , Rajasekharreddy pala, Asad Syad, Ali H. Bahkali and Abdallah M. Elgorban. 2016. Chrysin -loaded chitosan Nanoparticle potentiated Antibiofilm against staphylococcus aureus. PP.1-11.
21. Saeed Samarghandian , Mohsen Azimi- Nezhad, Fariborz Samini , Tahereh Farrkhonedeh. 2015. Chrysin treatment improves diabetes and its complications in streptozotocin-induced diabetic rats. J. Physiol . pharmacol. PP. 1-19.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
.